Ginger : Bloating and Intestinal Gas
B エビデンス 少なくとも1件のランダム化試験がこれを支持しており、おおむね一貫した結果が得られています。Consistent evidence across motion sickness, pregnancy nausea, and chemotherapy-induced nausea. 1-2 g/day reduces nausea severity. Strongest evidence for pregnancy-related nausea.
結論
Consistent evidence across motion sickness, pregnancy nausea, and chemotherapy-induced nausea. 1-2 g/day reduces nausea severity. Strongest evidence for pregnancy-related nausea.
Key Study Findings
対象集団: NSCLC patients receiving carboplatin-based chemotherapy
対象集団: Patients with functional dyspepsia (mean age 51.5, 78.7% female)
対象集団: IBS patients
対象集団: Patients with relapsing-remitting multiple sclerosis
対象集団: Ibs-d of spleen and kidney yang deficiency were randomly divided into
対象集団: Patients with FD and IBS overlap
Key Statistics
27
研究数
4000
参加者数
Positive
グレード
Referenced Papers
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
一般的な使用量
- general:
- 250 mg-1 g/day of dried ginger extract
- nauseasupport:
- 1-2 g/day in divided doses
- pregnancynausea:
- 250 mg four times daily (1 g/day; consult healthcare provider)
- dyspepsiasupport:
- 1-2 g with meals
上限量: Generally well-tolerated up to 4 g/day; 1 g/day recommended during pregnancy
研究で検討された用量
| 用量 | 期間 | 効果 | N |
|---|---|---|---|
| None | -- | Positive | 136 |
| 1080 mg/day in divided doses | 8 weeks | Positive | 47 |
| None | -- | Mixed | 828 |
| 80% | 12 weeks | Positive | 26 |
| 92.5% | 4 weeks | Positive | -- |
| None | 4 weeks | Positive | -- |
| None | -- | Mixed | -- |
| None | 12 weeks | Positive | -- |
推奨摂取タイミング: With meals or 30 minutes before meals for dyspepsia; any time for nausea
Safety & Side Effects
報告されている副作用
- ⚠ Heartburn and GI irritation (especially at higher doses or on empty stomach)
- ⚠ Mild blood-thinning effect at very high doses
- ⚠ Mouth and throat irritation from raw ginger
- ⚠ Diarrhea at excessive doses
既知の相互作用
- ● Anticoagulants (warfarin) and antiplatelet drugs (may enhance bleeding risk at high doses)
- ● Diabetes medications (may lower blood sugar; monitor glucose levels)
- ● Antihypertensive medications (may have additive blood pressure-lowering effects)
- ● Gallstone medications (ginger increases bile flow)
耐容上限摂取量: Generally well-tolerated up to 4 g/day; 1 g/day recommended during pregnancy
サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。
Frequently Asked Questions
Does Ginger help with Bloating and Intestinal Gas?
How much Ginger should I take for Bloating and Intestinal Gas?
Are there side effects of Ginger?
How strong is the evidence for Ginger and Bloating and Intestinal Gas?
Related Evidence
に関する他の成分: Bloating and Intestinal Gas
Ginger 他の症状・状態について
References
- [1] Lemlem Gebremariam Aregawi et al.. Curr Ther Res Clin Exp. 2025. Evaluation of Adverse Effects and Tolerability of Dietary Ginger Supplementation in Patients With Functional Dyspepsia. doi:10.1016/j.curtheres.2025.100792 PubMed
- [2] Kerun Cai et al.. Anticancer Agents Med Chem. 2025. Jianpi Yiwei Granules for Chemotherapy-Induced Gastrointestinal Reactions: A Randomized Double-Blind Placebo-Controlled Trial. doi:10.2174/0118715206427314251002153843 PubMed
- [3] Salmeen D Babelghaith et al.. Saudi Pharm J. 2024. The use of complementary and alternative medicine for functional gastrointestinal disorders among the saudi population. doi:10.1016/j.jsps.2024.102084 PubMed
- [4] Sahar Foshati et al.. BMC Complement Med Ther. 2023. The effects of ginger supplementation on common gastrointestinal symptoms in patients with relapsing-remitting multiple sclerosis: a double-blind randomized placebo-controlled trial. doi:10.1186/s12906-023-04227-x PubMed
- [5] Zheng-Rong Zhao et al.. Zhongguo Zhen Jiu. 2023. [Herbal-moxa plaster for diarrhea type irritable bowel syndrome of spleen and kidney yang deficiency: a randomized controlled trial]. doi:10.13703/j.0255-2930.20220804-k0001 PubMed
- [6] Soeren Klaus Buentzel et al.. In Vivo. 2022. Medicinal Plants Used for Abdominal Discomfort - Information from Cancer Patients and Medical Students. doi:10.21873/invivo.12976 PubMed
- [7] Franchek Drobnic et al.. Minerva Gastroenterol (Torino). 2022. Efficacy of artichoke and ginger extracts with simethicone to treat gastrointestinal symptoms in endurance athletes: a pilot study. doi:10.23736/S2724-5985.20.02664-1 PubMed
- [8] Sanjib Kumar Panda MPharm et al.. J Diet Suppl. 2022. A Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Comparative Clinical Study to Evaluate the Efficacy and Safety of OLNP-06 versus Placebo in … doi:10.1080/19390211.2020.1856996 PubMed
- [9] Francesco Di Pierro et al.. Minerva Gastroenterol Dietol. 2020. Effectiveness of a nutraceutical supplement containing highly standardized perilla and ginger extracts in patients with functional dyspepsia. doi:10.23736/S1121-421X.19.02650-3 PubMed
- [10] Kentaro Nobutani et al.. Pharmacol Res Perspect. 2017. Daikenchuto (TU-100) alters murine hepatic and intestinal drug metabolizing enzymes in an in vivo dietary model: effects of gender and … doi:10.1002/prp2.361 PubMed
- [11] Attilio Giacosa et al.. Evid Based Complement Alternat Med. 2015. The Effect of Ginger (Zingiber officinalis) and Artichoke (Cynara cardunculus) Extract Supplementation on Functional Dyspepsia: A Randomised, Double-Blind, and Placebo-Controlled … doi:10.1155/2015/915087 PubMed
- [12] Michael Sanatani et al.. J Complement Integr Med. 2015. Tolerability of the combination of ginger (Zingiber officinalis), gentian (Gentiana lutea) and turmeric (Curcuma longa) in patients with cancer-associated anorexia. doi:10.1515/jcim-2013-0064 PubMed
- [13] Raghavendra Haniadka et al.. Food Funct. 2013. A review of the gastroprotective effects of ginger (Zingiber officinale Roscoe). doi:10.1039/c3fo30337c PubMed
- [14] Seng-Kee Chuah et al.. J Neurogastroenterol Motil. 2011. The effects of ginger on gallbladder motility in healthy male humans. doi:10.5056/jnm.2011.17.4.411 PubMed
- [15] Y K Gupta et al.. Methods Find Exp Clin Pharmacol. 2001. Reversal of pyrogallol-induced delay in gastric emptying in rats by ginger (Zingiber officinale). doi:10.1358/mf.2001.23.9.662137 PubMed
FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。